These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7607229)
41. Maduropeptin: an antitumor chromoprotein with selective protease activity and DNA cleaving properties. Zein N; Solomon W; Colson KL; Schroeder DR Biochemistry; 1995 Sep; 34(36):11591-7. PubMed ID: 7547890 [TBL] [Abstract][Full Text] [Related]
42. Quantum chemical and molecular mechanics studies on the binding of stereoisomers of the oligopeptide antibiotics amidinomycin and noformycin to the minor groove of B-DNA. Sapse AM; Feng W; Fugler-Domenico L; Kabir S; Joseph T; Lown JW J Biomol Struct Dyn; 1993 Feb; 10(4):709-26. PubMed ID: 8466675 [TBL] [Abstract][Full Text] [Related]
43. Some characteristics of DNA strand scission by macromolecular antitumor antibiotic C-1027 containing a novel enediyne chromophore. Sugiura Y; Matsumoto T Biochemistry; 1993 Jun; 32(21):5548-53. PubMed ID: 8504075 [TBL] [Abstract][Full Text] [Related]
44. NMR investigation of Hoogsteen base pairing in quinoxaline antibiotic--DNA complexes: comparison of 2:1 echinomycin, triostin A and [N-MeCys3,N-MeCys7] TANDEM complexes with DNA oligonucleotides. Addess KJ; Feigon J Nucleic Acids Res; 1994 Dec; 22(24):5484-91. PubMed ID: 7816641 [TBL] [Abstract][Full Text] [Related]
45. Semi-empirical, ab initio and molecular modeling studies on the DNA binding of a calicheamicinone-polyamide conjugate. Sapse AM; Rothchild R; Lown JW J Biomol Struct Dyn; 2000 Dec; 18(3):423-31. PubMed ID: 11149518 [TBL] [Abstract][Full Text] [Related]
46. Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists. Ho SN; Boyer SH; Schreiber SL; Danishefsky SJ; Crabtree GR Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9203-7. PubMed ID: 7937742 [TBL] [Abstract][Full Text] [Related]
47. The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage. Drak J; Iwasawa N; Danishefsky S; Crothers DM Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7464-8. PubMed ID: 1881884 [TBL] [Abstract][Full Text] [Related]
48. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns. Vaiana AC; Westhof E; Auffinger P Biochimie; 2006 Aug; 88(8):1061-73. PubMed ID: 16824662 [TBL] [Abstract][Full Text] [Related]
49. Molecular recognition by secondary metabolites. Williams DH; Stone MJ; Mortishire-Smith RJ; Hauck PR Biochem Pharmacol; 1990 Jul; 40(1):27-34. PubMed ID: 2372307 [TBL] [Abstract][Full Text] [Related]
50. DNA binding and cleavage by enediyne antitumor antibiotics, esperamicin and dynemicin. Shiraki T; Sugiura Y Nucleic Acids Symp Ser; 1989; (21):53-4. PubMed ID: 2608476 [TBL] [Abstract][Full Text] [Related]
51. DNA binding and cleavage of a novel antitumor antibiotic dynemicin A: detection of binding and cleavage sites by exonuclease III digestion and alkali-induced cutting reactions. Arakawa T; Kusakabe T; Kuwahara J; Otsuka M; Sugiura Y Biochem Biophys Res Commun; 1993 Jan; 190(2):362-70. PubMed ID: 8427581 [TBL] [Abstract][Full Text] [Related]
52. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition. Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560 [TBL] [Abstract][Full Text] [Related]
53. Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA. Cashman DJ; Scarsdale JN; Kellogg GE Nucleic Acids Res; 2003 Aug; 31(15):4410-6. PubMed ID: 12888500 [TBL] [Abstract][Full Text] [Related]
54. Binding of quinomycin antibiotic UK-65,662 to DNA: 1H-n.m.r. studies of drug-induced changes in DNA conformation in complexes with d(ACGT)2 and d(GACGTC)2. Searle MS Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):967-79. PubMed ID: 7818504 [TBL] [Abstract][Full Text] [Related]
55. Alterations of binding mode and cutting site by G-->I replacement in preferred cleavage sequences 5'-AGG of chromoprotein C-1027. Matsumoto T; Sugiura Y Biochem Biophys Res Commun; 1994 Dec; 205(3):1533-8. PubMed ID: 7811233 [TBL] [Abstract][Full Text] [Related]
56. Structure, dynamics and hydration of the nogalamycin-d(ATGCAT)2Complex determined by NMR and molecular dynamics simulations in solution. Williams HE; Searle MS J Mol Biol; 1999 Jul; 290(3):699-716. PubMed ID: 10395824 [TBL] [Abstract][Full Text] [Related]
57. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin. Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822 [TBL] [Abstract][Full Text] [Related]
58. Structural, conformational, and theoretical binding studies of antitumor antibiotic porfiromycin (N-methylmitomycin C), a covalent binder of DNA, by X-ray, NMR, and molecular mechanics. Arora SK; Cox MB; Arjunan P J Med Chem; 1990 Nov; 33(11):3000-8. PubMed ID: 2231597 [TBL] [Abstract][Full Text] [Related]
59. Recognition elements that determine affinity and sequence-specific binding to DNA of 2QN, a biosynthetic bis-quinoline analogue of echinomycin. Bailly C; Echepare S; Gago F; Waring MJ Anticancer Drug Des; 1999 Jun; 14(3):291-303. PubMed ID: 10500504 [TBL] [Abstract][Full Text] [Related]
60. Conformational constraint as a means for understanding RNA-aminoglycoside specificity. Blount KF; Zhao F; Hermann T; Tor Y J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]